Ingested Type I Interferon—State of the Art as Treatment for Autoimmunity Part 2

por Brod, Staley A.
Publicado 2010

Review of approved NMO therapies based on mechanism of action, efficacy and long-term effects

por Brod, Staley A.
Publicado 2020

Plegia to walking: AHSCBMT in severe NMOSD relapse

por Carlisle, Nicola, Hari, Parameswaran, Brod, Staley
Publicado 2020

Tumefactive demyelination: Clinical outcomes, lesion evolution and treatments

por Brod, Staley A, Lindsey, J William, Nelson, Flavia
Publicado 2019

Ingested (Oral) Adrenocorticotropic Hormone Inhibits IL-17 in the Central Nervous System in the Mouse Model of Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis

por Dittel, Landon J., Dittel, Bonnie N., Brod, Staley A.
Publicado 2022

Clinical and MRI efficacy of sc IFN β-1a tiw in patients with relapsing MS appearing to transition to secondary progressive MS: post hoc analyses of PRISMS and SPECTRIMS

por Freedman, Mark S., Brod, Staley, Singer, Barry A., Cohen, Bruce A., Hayward, Brooke, Dangond, Fernando, Coyle, Patricia K.
Publicado 2019

Chronic Cerebrospinal Venous Insufficiency: Case–Control Neurosonography Results

por Barreto, Andrew D, Brod, Staley A, Bui, Thanh-Tung, Jemelka, James R, Kramer, Larry A, Ton, Kelly, Cohen, Alan M, Lindsey, John W, Nelson, Flavia, Narayana, Ponnada A, Wolinsky, Jerry S
Publicado 2013

Effect of Ingested Interferon-α on β-Cell Function in Children With New-Onset Type 1 Diabetes

por Rother, Kristina I., Brown, Rebecca J., Morales, Miriam M., Wright, Elizabeth, Duan, Zhigang, Campbell, Carol, Harlan, David M., Orlander, Philip R., Brod, Staley A., Hardin, Dana S., Popovic, Jadranka, McEvoy, Robert C.
Publicado 2009